Literature DB >> 15978235

Prostatitis and serum prostate-specific antigen.

Puneet Sindhwani1, Christopher M Wilson.   

Abstract

Prostatitis is an inflammatory condition of the prostate and has been divided into four categories according to the National Institutes of Health classification. This article reviews the various types of prostatitis and their effect on serum prostate-specific antigen levels. Various proposed mechanisms of this elevation include leakage of prostate-specific antigen (PSA) into the blood stream, hypervascularity, and altered vascular permeability secondary to inflammation. Acute prostatitis can lead to an increase in PSA, which usually returns to normal levels with appropriate antibiotics within 1 to 3 months. Patients with chronic prostatitis have a less well-defined decrease in PSA after an antibiotic course. Whether a course of antibiotics prior to biopsy increases the yield has not been well established. Asymptomatic inflammation of the prostate has been recognized to be an important confounding factor in patients with an elevated PSA. Inflammation has been proposed to be a precursor of prostate adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15978235     DOI: 10.1007/s11934-005-0029-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  46 in total

1.  Elevation of prostate specific antigen from bacillus Calmette-Guerin-induced granulomatous prostatitis.

Authors:  R R Bahnson
Journal:  J Urol       Date:  1991-11       Impact factor: 7.450

2.  Treatment of chronic prostatitis lowers serum prostate specific antigen.

Authors:  Caleb B Bozeman; Brett S Carver; James A Eastham; Dennis D Venable
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

3.  Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer.

Authors:  K Okada; M Kojima; Y Naya; K Kamoi; K Yokoyama; T Takamatsu; T Miki
Journal:  Urology       Date:  2000-06       Impact factor: 2.649

Review 4.  Molecular forms of serum prostate-specific antigen. The clinical value of percent free prostate-specific antigen.

Authors:  P A Abrahamsson; H Lilja; J E Oesterling
Journal:  Urol Clin North Am       Date:  1997-05       Impact factor: 2.241

5.  Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen.

Authors:  J Morote; M Lopez; G Encabo; I M de Torres
Journal:  Eur Urol       Date:  2000-05       Impact factor: 20.096

6.  Diagnosis and treatment of prostatitis in Canada.

Authors:  J C Nickel; M Nigro; L Valiquette; P Anderson; A Patrick; J Mahoney; R Buckley; J Corcos; D Hosking
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

7.  Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate.

Authors:  D E Neal; S Clejan; D Sarma; T D Moon
Journal:  Prostate       Date:  1992       Impact factor: 4.104

8.  Total and free serum prostate specific antigen levels during the first month of acute prostatitis.

Authors:  Xavier Gamé; Sébastien Vincendeau; Robert Palascak; Stéphane Milcent; Robert Fournier; Alain Houlgatte
Journal:  Eur Urol       Date:  2003-06       Impact factor: 20.096

9.  Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer.

Authors:  Cheol Kwak; Ja Hyeon Ku; Taehun Kim; Dal Woo Park; Ki Young Choi; Eunsik Lee; Sang Eun Lee; Chongwook Lee
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

10.  Effect of NIH-IV prostatitis on free and free-to-total PSA.

Authors:  Igor Stancik; Werner Lüftenegger; Martin Klimpfinger; Matthias M Müller; Wolfgang Hoeltl
Journal:  Eur Urol       Date:  2004-12       Impact factor: 20.096

View more
  12 in total

1.  Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.

Authors:  Antonio B Porcaro; Giovanni Novella; Daniele Mattevi; Leonardo Bizzotto; Giovanni Cacciamani; Nicolò De Luyk; Irene Tamanini; Maria A Cerruto; Matteo Brunelli; Walter Artibani
Journal:  Curr Urol       Date:  2016-05-20

2.  Risk factors for prostate cancer detection after a negative biopsy: a novel multivariable longitudinal approach.

Authors:  Peter H Gann; Angela Fought; Ryan Deaton; William J Catalona; Edward Vonesh
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

3.  High rate of detection of ultrasound signs of prostatitis in patients with HPV-DNA persistence on semen: role of ultrasound in HPV-related male accessory gland infection.

Authors:  S La Vignera; R A Condorelli; R Cannarella; F Giacone; L Mongioi'; G Scalia; V Favilla; G I Russo; S Cimino; G Morgia; A E Calogero
Journal:  J Endocrinol Invest       Date:  2019-06-04       Impact factor: 4.256

4.  Screening for prostate cancer: a controversy or fact.

Authors:  S Stavridis; S Saidi; Lj Lekovski; S Dohcev; G Spasovski
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

5.  Pathological Outcome following Radical Prostatectomy in Men with Prostate Specific Antigen Greater than 10 ng/ml and Histologically Favorable Risk Prostate Cancer.

Authors:  Jiwoong Yu; Young Suk Kwon; Sinae Kim; Christopher Sejong Han; Nicholas Farber; Jongmyung Kim; Seok Soo Byun; Wun-Jae Kim; Seong Soo Jeon; Isaac Yi Kim
Journal:  J Urol       Date:  2015-12-01       Impact factor: 7.450

6.  The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.

Authors:  Luke Pardy; Rayna Rosati; Claire Soave; Yanfang Huang; Seongho Kim; Manohar Ratnam
Journal:  Prostate       Date:  2019-12-03       Impact factor: 4.104

7.  Antibacterial therapy improves the effectiveness of prostate cancer detection using prostate-specific antigen in patients with asymptomatic prostatitis.

Authors:  Ping Tang; Ke-Ji Xie; Bin Wang; Xiang-Rong Deng; Ru-Biao Ou
Journal:  Int Urol Nephrol       Date:  2009-06-23       Impact factor: 2.370

8.  Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.

Authors:  Antonio B Porcaro; Daniele Mattevi; Giovanni Novella; Nicolò De Luyk; Paolo Corsi; Leonardo Bizzotto; Davide De Marchi; Marco Sebben; Alessandro Tafuri; Davide Inverardi; Tania Processali; Maria A Cerruto; Matteo Brunelli; Salvatore Siracusano; Walter Artibani
Journal:  Curr Urol       Date:  2017-12-30

9.  Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration.

Authors:  S Sutcliffe; R L Nevin; R Pakpahan; D J Elliott; S R Cole; A M De Marzo; C A Gaydos; W B Isaacs; W G Nelson; L J Sokoll; J M Zenilman; S B Cersovsky; E A Platz
Journal:  Br J Cancer       Date:  2011-07-26       Impact factor: 7.640

10.  Chikungunya Virus Infection and Acute Elevation of Serum Prostate-Specific Antigen.

Authors:  William Derval Aiken; Joshua J Anzinger
Journal:  Case Rep Urol       Date:  2015-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.